CASP3 and prostate carcinoma: We have previously shown that direct inhibition of the catalytic activity of caspase 3 did result in partial protection against LCA-induced cytotoxicity in LNCaP and PC-3 prostate cancer cells (Goldberg et al., 2013), and in neuroblastoma cells (Goldberg et al., 2011).